New era for ME/CFS research as top cytokine study attracts media headlines
The immune systems of patients who have recently developed ME/CFS look markedly different from those who have been ill for much longer, according to a major new study from Drs. Ian Lipkin and Mady Hornig at Columbia University. This shift in immune function hadn’t been seen before.
Discuss the article on the Forums.

THREE ADDITIONAL PATIENTS NEEDED FOR MELAS STUDY

Discussion in 'Active Clinical Studies' started by ggingues, May 18, 2011.

  1. ggingues

    ggingues $10 gift code at iHerb GAS343 of $40

    Messages:
    4,283
    Likes:
    1,139
    Concord, NH
    Columbia University in New York City is seeking three study participants for a double-blind, placebo controlled clinical trial of idebenone in MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes).

    The Phase IIa study will compare two different doses of an experimental medication, idebenone, administered over a one month period to determine the efficacy of the drug. People with MELAS and the 3243 mutation, aged 8-65 years, may be eligible.

    The main goal of the clinical trial is to determine if idebenone has an effect on brain lactate as measured by magnetic resonance spectroscopy (MRS). MRS is done in an MRI scanner, and is safe and typically well tolerated.

    An additional goal is to study the safety and tolerability of idebenone in people with MELAS. If you or a family member would like more information regarding this study please see our website or contact the Research Coordinator, Kris Engelstad, at 212.305.6834. Click here to visit the trial website.

    http://giblinlab.org/studies.html
     
  2. ggingues

    ggingues $10 gift code at iHerb GAS343 of $40

    Messages:
    4,283
    Likes:
    1,139
    Concord, NH
    Not sure if this will be applicable to us, but thought I would post it anyways.
     

See more popular forum discussions.

Share This Page